Lapidus Stanley 4
4 · T2 Biosystems, Inc. · Filed Jun 13, 2019
Insider Transaction Report
Form 4
Lapidus Stanley
Director
Transactions
- Sale
Common Stock
2019-06-11$1.44/sh−9,000$12,960→ 53,010 total
Footnotes (2)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2019, to cover payment of tax liability incident to the vesting of restricted stock units.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.46. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.